References
- Liso V, Specchia G, Pogliani EM, Palumbo G, Mininni D, Rossi V, Teruzzi E, Mestice A, Coppi MR, Biondi A. Extramedullar)- involvement in patients with acute promyelocyte leukemia: a report of seven cases. Cancer 1998; 83: 1522–1528
- Lugassy G, Halperin Y. Pituitary relapse of acute promyelocyte leukemia after ATRA. International Journal of Hematology 1998; 68: 101–102
- Evans G, Grimwade D, Prentice HG, Simpson N. Central nervous system relapse in acute promyelocytic leukemia in patients treated with all-trans retinoic acid. British Journal of Haematology 1997; 98: 437–439
- Warrell RP Frankel SR, Miller WH, Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). The New England Journal of Medicine 1991; 324: 1385–1393
- Weiss MA, Warrell RP, Jr. Two cases of extramedullary acute promyelocytic leukemia. Cancer 1994; 74: 1882–1886
- Muindi JR, Frankel SR, Huselton C., DeGrazia F, Garland WA, Young CW, Warrell RP. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Research 1992; 52: 2138–2142